DHPYX | VEVYX | DHPYX / VEVYX | |
Total Expense Ratio | 0.65 | 0.66 | 98% |
Annual Report Gross Expense Ratio | 0.65 | 0.66 | 98% |
Fund Existence | 11 years | 12 years | - |
Gain YTD | 1.678 | -2.585 | -65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 1000000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 127M | 17.2B | 1% |
Annual Yield % from dividends | 1.25 | 1.12 | 111% |
Returns for 1 year | -0.18 | -7.25 | 2% |
Returns for 3 years | -0.47 | -5.90 | 8% |
Returns for 5 years | 45.19 | 29.06 | 156% |
Returns for 10 years | 63.37 | 43.53 | 146% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SBIO | 31.58 | 0.57 | +1.84% |
ALPS Medical Breakthroughs ETF | |||
FDL | 42.09 | 0.44 | +1.06% |
First Trust Morningstar Div Leaders ETF | |||
CHI | 10.23 | 0.07 | +0.69% |
Calamos Convertible Opportunities and Income Fund | |||
GLO | 5.31 | 0.01 | +0.19% |
Clough Global Opportunities Fund | |||
SNPG | 45.84 | N/A | N/A |
Xtrackers S&P 500 Growth Scrd & Scrn ETF |